O’Connor, K. C. et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat. Med. 13, 211–217 (2007).

Article  PubMed  PubMed Central  Google Scholar 

Solomon, A. J. et al. Differential diagnosis of suspected multiple sclerosis: an updated consensus approach. Lancet Neurol. 22, 750–768 (2023).

Article  PubMed  Google Scholar 

Borisow, N., Mori, M., Kuwabara, S., Scheel, M. & Paul, F. Diagnosis and treatment of NMO spectrum disorder and MOG-encephalomyelitis. Front. Neurol. 9, 888 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Jarius, S. et al. Neuromyelitis optica. Nat. Rev. Dis. Prim. 6, 85 (2020).

Article  PubMed  Google Scholar 

Marignier, R. et al. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 20, 762–772 (2021).

Article  CAS  PubMed  Google Scholar 

Lennon, V. A. et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364, 2106–2112 (2004).

Article  CAS  PubMed  Google Scholar 

Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S. & Hinson, S. R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202, 473–477 (2005).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kremer, L. et al. Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients. Mult. Scler. 20, 843–847 (2014).

Article  CAS  PubMed  Google Scholar 

Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J. & Weinshenker, B. G. The spectrum of neuromyelitis optica. Lancet Neurol. 6, 805–815 (2007).

Article  CAS  PubMed  Google Scholar 

Wingerchuk, D. M. et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85, 177–189 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Waters, P. et al. Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica. J. Neurol. Neurosurg. Psychiat. 87, 1005–1015 (2016).

Article  PubMed  Google Scholar 

Pandit, L. et al. Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India. Mult. Scler. J. Exp. Transl. Clin. 2, 2055217316675634 (2016).

PubMed  PubMed Central  Google Scholar 

Banwell, B. et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 22, 268–282 (2023).

Article  CAS  PubMed  Google Scholar 

Zamvil, S. S. & Slavin, A. J. Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? Neurol. Neuroimmunol. Neuroinflamm. 2, e62 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Jarius, S. & Wildemann, B. The history of neuromyelitis optica. J. Neuroinflamm. 10, 797 (2013).

Article  Google Scholar 

Devic, E. Myèlite aigüe compliquée de névrite optique. Bull. Med. 8, 1033–1034 (1894).

Google Scholar 

Jarius, S. & Wildemann, B. Devic’s index case: a critical reappraisal—AQP4-IgG-mediated neuromyelitis optica spectrum disorder, or rather MOG encephalomyelitis? J. Neurol. Sci. 407, 116396 (2019).

Article  CAS  PubMed  Google Scholar 

Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F. & Weinshenker, B. G. Revised diagnostic criteria for neuromyelitis optica. Neurology 66, 1485–1489 (2006).

Article  CAS  PubMed  Google Scholar 

Haase, C. G. et al. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J. Neuroimmunol. 114, 220–225 (2001).

Article  CAS  PubMed  Google Scholar 

Mader, S. et al. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J. Neuroinflamm. 8, 184 (2011).

Article  CAS  Google Scholar 

Sato, D. K. et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82, 474–481 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jurynczyk, M. et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain 140, 3128–3138 (2017).

Article  PubMed  Google Scholar 

Kitley, J. et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol. 71, 276–283 (2014).

Article  PubMed  Google Scholar 

Brilot, F. et al. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann. Neurol. 66, 833–842 (2009).

Article  CAS  PubMed  Google Scholar 

Pohl, D. et al. Acute disseminated encephalomyelitis: updates on an inflammatory CNS syndrome. Neurology 87, S38–S45 (2016).

Article  PubMed  Google Scholar 

Bruijstens, A. L. et al. HLA association in MOG-IgG- and AQP4-IgG-related disorders of the CNS in the Dutch population. Neurol. Neuroimmunol. Neuroinflamm. 7, e702 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Bagherieh, S. et al. Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis. Neurol. Sci. 44, 1905–1915 (2023).

Article  PubMed  Google Scholar 

Pandit, L., D’Cunha, A. & Malapur, P. U. Incidence and prevalence of neuromyelitis optica spectrum disorders in the background of international consensus diagnostic criteria — a systematic review. Neurol. India 70, 1771–1779 (2022).

Article  PubMed  Google Scholar 

Papp, V. et al. Worldwide incidence and prevalence of neuromyelitis optica: a systematic review. Neurology 96, 59–77 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Moghadasi, A. N., Mirmosayyeb, O., Mohammadi, A., Sahraian, M. A. & Ghajarzadeh, M. The prevalence of cognitive impairment in patients with neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis. Mult. Scler. Relat. Disord. 49, 102757 (2021).

Article  PubMed  Google Scholar 

Marrie, R. A. & Gryba, C. The incidence and prevalence of neuromyelitis optica: a systematic review. Int. J. MS Care 15, 113–118 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Carnero Contentti, E. et al. Neuromyelitis optica spectrum disorder in Latin America: state-of-the-art and current challenges. J. Integr. Neurosci. 23, 74 (2024).

Article  PubMed  Google Scholar 

Flanagan, E. P. et al. Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum. Ann. Neurol. 79, 775–783 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hor, J. Y. et al. Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide. Front. Neurol. 11, 501 (2020).